At 12.9% CAGR, Europe Maqui Berries Market is Projected to be Worth US$ 20.60 Million by 2030, says Business Market Insights

According to Business Market Insights research, the Europe maqui berries market was valued at US$ 7.78 million in 2022 and is expected to reach US$ 20.60 million by 2030, registering a CAGR of 12.9% from 2022 to 2030. Development of medicines with maqui berry extracts that support eye health and rising popularity of skin care products with maqui berry are among the critical factor attributed to the Europe maqui berries market expansion.

Dry eye happens when tear glands in the eyes do not make enough tears to stay wet and lubricated. This causes irritation in the eyes, redness, sensitivity to light, blurry vision, and a stinging or burning feeling. Dry eyes, if left untreated, can cause severe eye inflammation, corneal ulcers, abrasion of corneal surface, and vision loss. Since maqui berries are antioxidant-rich superfruits, it is seen that they can help reduce dry eye symptoms by reducing inflammation, increasing natural tear production, and improving tear quality.

These oral supplements support healthy tear fluid generation and is a safer alternative to artificial tears. The company also conducted trials to see the effect of MaquiBright extract on dry eye discomfort. The participants reported significant improvement in tear production and dry eye discomfort. Thus, the rising development of innovative medicines and supplements with maqui berry extracts that support eye health is expected to open lucrative opportunities for the Europe maqui berry market in the coming years.

On the contrary, limited supply of maqui berries hampers the growth of Europe Maqui Berries market.

Based on form, the Europe maqui berries market is bifurcated into fresh and processed. The processed segment held 93.5% share of Europe maqui berries market in 2022, amassing US$ 7.28 million. It is projected to garner US$ 19.33 million by 2030 to expand at 13.0% CAGR during 2022-2030.

By category, the Europe maqui berries market is bifurcated into organic and conventional. The conventional segment held 68.8% share of Europe maqui berries market in 2022, amassing US$ 5.35 million. It is projected to garner US$ 13.98 million by 2030 to expand at 12.8% CAGR during 2022-2030.

In terms of application, the Europe maqui berries market is segmented into functional food and beverages, pharmaceuticals and nutraceuticals, personal care and cosmetics and animal nutrition. The functional food and beverages segment held 50.9% share of Europe maqui berries market in 2022, amassing US$ 3.96 million. It is projected to garner US$ 10.20 million by 2030 to expand at 12.5% CAGR during 2022-2030.

Based on country, the Europe maqui berries market has been categorized into Germany, France, the UK, Italy, Russia, and the Rest of Europe. Our regional analysis states that the Rest of Europe captured 55.4% share of Europe maqui berries market in 2022. It was assessed at US$ 4.31 million in 2022 and is likely to hit US$ 10.87 million by 2030, exhibiting a CAGR of 12.2% during 2022-2030.

Key players operating in the Europe maqui berries market are Abbott Blackstone Co, HP Ingredients Corp, Shaanxi LonierHerb Bio-Technology Co Ltd, and Xi'an Herb Bio-Tech Co Ltd, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com